Literature DB >> 1489128

Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill.

M J O'Doherty1, S H Thomas, C J Page, D F Treacher, T O Nunan.   

Abstract

Several factors may affect the delivery of a nebulized aerosol to the lung through an endotracheal tube during mechanical ventilation. To study these factors in vitro, a model representing ventilation of an adult patient was constructed by linking a Servo 900C ventilator to a standard humidified circuit and an endotracheal (ET) tube positioned within a pipe representing the trachea. This was connected via a filter to a lung simulator. Nebulizers filled with 99mTc human serum albumin were positioned in the circuit, and the delivery of nebulized aerosol through the ET tube into the filter was measured using a gamma camera. With the use of an inspiratory phase-activated System 22 Acorn jet nebulizer, typical adult ventilator settings, and a 3-ml nebulizer solution volume, 5.4% of the nebulizer dose reached beyond the end of the ET tube. This was increased by increasing the inspiratory time, reducing the respiratory rate or respiratory minute volume, and by repositioning the nebulizer on the inspiratory limb of the Y-piece and was reduced by slowing the driving gas flow to the nebulizer. Under the same conditions, delivery was 3.1 and 4.4% using the Samsonic and Fisoneb ultrasonic nebulizers, respectively. Increasing the fill volume and the addition of an aerosol storage chamber increased delivery with all three nebulizers. These experiments suggest some simple ways of improving aerosol delivery during mechanical ventilation, including increasing the volume of nebulizer fill, repositioning the nebulizer in the ventilator circuit, adding an aerosol storage chamber, and adjusting ventilator settings to maximize delivery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489128     DOI: 10.1164/ajrccm/146.2.383

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system.

Authors:  M L Everard; S G Devadason; P N Le Souëf
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 2.  Aerosol delivery to ventilated newborn infants: historical challenges and new directions.

Authors:  Jan Mazela; Richard A Polin
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

Review 3.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Nebulisation of surfactants in an animal model of neonatal respiratory distress.

Authors:  T F Fok; M al-Essa; M Dolovich; F Rasid; H Kirpalani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

Review 5.  Nebuliser therapy in childhood.

Authors:  P W Barry; C O'Callaghan
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 6.  Nebuliser therapy in the intensive care unit.

Authors:  M J O'Doherty; S H Thomas
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 7.  Aerosol delivery via invasive ventilation: a narrative review.

Authors:  Hui-Ling Lin; James B Fink; Huiqing Ge
Journal:  Ann Transl Med       Date:  2021-04

Review 8.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

9.  Pulmonary deposition of a nebulised aerosol during mechanical ventilation.

Authors:  S H Thomas; M J O'Doherty; H M Fidler; C J Page; D F Treacher; T O Nunan
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

10.  Aerosol delivery by an ultrasonic nebulizer during different mechanical ventilation settings in a lung model--a pilot study.

Authors:  Michael Winterhalter; Michael Bund; Nawid Khaladj; Christian Hagl; Andre Simon; Ludwig Hoy; Siegfried Piepenbrock; Niels Rahe-Meyer
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.